《2021年变应性鼻炎和鼻科学国际共识声明：鼻窦炎》

International consensus statement on allergy and rhinology: rhinosinusitis 2021.

作者信息

Orlandi Richard R, Kingdom Todd T, Smith Timothy L, Bleier Benjamin, DeConde Adam, Luong Amber U, Poetker David M, Soler Zachary, Welch Kevin C, Wise Sarah K, Adappa Nithin, Alt Jeremiah A, Anselmo-Lima Wilma Terezinha, Bachert Claus, Baroody Fuad M, Batra Pete S, Bernal-Sprekelsen Manuel, Beswick Daniel, Bhattacharyya Neil, Chandra Rakesh K, Chang Eugene H, Chiu Alexander, Chowdhury Naweed, Citardi Martin J, Cohen Noam A, Conley David B, DelGaudio John, Desrosiers Martin, Douglas Richard, Eloy Jean Anderson, Fokkens Wytske J, Gray Stacey T, Gudis David A, Hamilos Daniel L, Han Joseph K, Harvey Richard, Hellings Peter, Holbrook Eric H, Hopkins Claire, Hwang Peter, Javer Amin R, Jiang Rong-San, Kennedy David, Kern Robert, Laidlaw Tanya, Lal Devyani, Lane Andrew, Lee Heung-Man, Lee Jivianne T, Levy Joshua M, Lin Sandra Y, Lund Valerie, McMains Kevin C, Metson Ralph, Mullol Joaquim, Naclerio Robert, Oakley Gretchen, Otori Nobuyoshi, Palmer James N, Parikh Sanjay R, Passali Desiderio, Patel Zara, Peters Anju, Philpott Carl, Psaltis Alkis J, Ramakrishnan Vijay R, Ramanathan Murugappan, Roh Hwan-Jung, Rudmik Luke, Sacks Raymond, Schlosser Rodney J, Sedaghat Ahmad R, Senior Brent A, Sindwani Raj, Smith Kristine, Snidvongs Kornkiat, Stewart Michael, Suh Jeffrey D, Tan Bruce K, Turner Justin H, van Drunen Cornelis M, Voegels Richard, Wang De Yun, Woodworth Bradford A, Wormald Peter-John, Wright Erin D, Yan Carol, Zhang Luo, Zhou Bing

机构信息

University of Utah, Salt Lake City, UT.

University of Colorado, Denver, CO.

出版信息

Int Forum Allergy Rhinol. 2021 Mar;11(3):213-739. doi: 10.1002/alr.22741.

DOI:10.1002/alr.22741

PMID:33236525

Abstract

UNLABELLED

EXECUTIVE SUMMARY

BACKGROUND: The 5 years since the publication of the first International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR-RS) has witnessed foundational progress in our understanding and treatment of rhinologic disease. These advances are reflected within the more than 40 new topics covered within the ICAR-RS-2021 as well as updates to the original 140 topics. This executive summary consolidates the evidence-based findings of the document.

METHODS

ICAR-RS presents over 180 topics in the forms of evidence-based reviews with recommendations (EBRRs), evidence-based reviews, and literature reviews. The highest grade structured recommendations of the EBRR sections are summarized in this executive summary.

RESULTS

ICAR-RS-2021 covers 22 topics regarding the medical management of RS, which are grade A/B and are presented in the executive summary. Additionally, 4 topics regarding the surgical management of RS are grade A/B and are presented in the executive summary. Finally, a comprehensive evidence-based management algorithm is provided.

CONCLUSION

This ICAR-RS-2021 executive summary provides a compilation of the evidence-based recommendations for medical and surgical treatment of the most common forms of RS.

摘要